Literature DB >> 12514435

Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999): implications for treatment of gonorrhea.

Rafael Llanes1, Jorge Sosa, Daymi Guzmán, Alina Llop, Eduardo A Valdés, Isabel Martínez, Sara Palma, María I Lantero.   

Abstract

BACKGROUND: Antibiotic-resistant strains of Neisseria gonorrhoeae, especially those resistant to penicillin and tetracycline, have spread with remarkable rapidity in many Caribbean countries. GOAL: The goal of the study was to survey the antibiotic susceptibilities of N gonorrhoeae strains isolated from 1995 to 1999 in Cuba and to discuss the impact of antimicrobial resistance on the management of gonorrhea in the country. STUDY
DESIGN: Susceptibility of the strains to penicillin, tetracycline, cefuroxime, ceftriaxone, ciprofloxacin, spectinomycin, and azithromycin were determined by an agar dilution method.
RESULTS: Penicillin and tetracycline resistance was noted in 60.8% and 54.2%, respectively, of the N gonorrhoeae strains tested. A total of 63.35 (76/120) of the N gonorrhoeae strains exhibited plasmid-mediated resistance to penicillin, tetracycline, or both. Strains with chromosomally mediated resistance to these antibiotics accounted for 10% (12/120) of the strains. The strains were susceptible to ceftriaxone, cefuroxime, spectinomycin, and ciprofloxacin. One strain's ciprofloxacin MIC was 0.125 mircog/ml. Of the 52 strains tested, 23.1% displayed intermediate resistance to azithromycin.
CONCLUSIONS: N gonorrhoeae strains exhibited a high frequency of resistance and multiresistance to penicillin and tetracycline. Therefore, these antibiotics should no longer be used to treat gonococcal infections in Cuba and should be substituted with effective drugs such as third-generation cephalosporins, spectinomycin, and fluoroquinolones. The detection of intermediate resistance to azithromycin and ciprofloxacin underlines the importance of periodic surveillance for susceptibility of N gonorrhoeae strains to antimicrobials agents used as primary therapy for gonorrhea.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514435     DOI: 10.1097/00007435-200301000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.

Authors:  J B Bulitta; C B Landersdorfer; M Kinzig; U Holzgrabe; F Sorgel
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

2.  Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba.

Authors:  Rafael Llanes; Claudia Soria; Shigeo Nagashima; Nobumichi Kobayashi; Angela Gala; Daymi Guzmán; Onelkis Feliciano; Lidunka Valdés; Oderay Gutiérrez; Heriberto Fernández; Alina Llop; Akihiro Wada
Journal:  J Health Popul Nutr       Date:  2010-04       Impact factor: 2.000

Review 3.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.